India Patent Cases
2,847 decisions indexed
Page 15 of 95 · 2,847 total
Bmi Group Danmark Aps (Formerly Icopal Danmark Aps) v.The Assistant Controller Of Patents And Designs And Another
Bmi Group Danmark Aps appealed a refusal order issued by the Controller of Patents and Designs regarding its patent application for a multi-layer sealing web. The core dispute centered on whether the invention possessed inventive step, specifically concerning the unique combination carrier insert featuring glass nonwoven and knitted glass reinforcement. The Delhi High Court examined the technical analysis and found that the Controller incorrectly interpreted the claim's features and relied improperly on non-analogous prior art. Consequently, the court allowed the appeal and directed the grant of the patent.
Huawei Techonologies Co. Ltd. v.The Controller General of Patents Designs and Trademark and Anr.
Huawei Technologies challenged the rejection of its patent application (No. 202237060506) by the Controller General of Patents. The initial rejection was based purely on procedural grounds, specifically alleging deficiencies in the General Power of Attorney (GPA). Huawei argued that this formalistic approach ignored the technical merits and violated principles of natural justice. The Calcutta High Court ultimately set aside the impugned order, finding the sole ground for rejection untenable, and remanded the matter to a new Hearing Officer.
Gunjan Sinha @ Kanishk Sinha v.Union Of India Ors
The appellants challenged the validity of Section 53 of the Patent Act, 1970, arguing that the delay in granting their patent (from application date to grant date) and subsequent demand for renewal fees violated constitutional rights. The court dismissed the appeal, holding that Section 53 is intra vires the Constitution and that the USA model of Patent Term Adjustment is not conducive to India.
Thyssenkrupp Rothe Erde Germany Gmbh v.IMO Holding Gmbh
The petitioner filed a Transfer Original Petition (Patents) challenging the validity of Patent IN254458, arguing that it lacked novelty and did not comply with relevant provisions of the Patents Act. However, the counsel for the petitioner subsequently informed the court that they had reached a settlement with the contesting respondent.
The Coca-Cola Company v.The Controller Of Patents & Anr.
The Coca-Cola Company appealed the refusal of its Indian Patent Application for a superior beverage dispenser. The appeal argued that the rejection order failed to analyze the appellant's submissions distinguishing the invention from cited prior art. The High Court held that the Controller must pass a speaking order analyzing all elements, and consequently set aside the impugned order, remanding the matter for fresh consideration.
R J Reynolds Tobacco Company (Sr 6/2020/PT/KOL) v.The Controller General Of Patents Designs and Trademarks And Anr
R J Reynolds Tobacco Company challenged the refusal of its patent application for a tobacco flavorant method, which was rejected solely on the grounds that all forms of tobacco are injurious to human health (Section 3(b) of the Patents Act). The petitioner argued that the rejection lacked any scientific basis or reasoning, being based merely on a preconceived notion. The Calcutta High Court agreed, finding the Assistant Controller's order unsubstantiated and arbitrary. Consequently, the court set aside the impugned order and remanded the matter for fresh consideration.
Vifor (International) Ag v.Controller Of Patents
Vifor (International) Ag appealed an order by the Assistant Controller rejecting its patent application for a pharmaceutical composition used to treat iron deficiency. The appellant argued that the rejection based on lack of novelty and inventive step was flawed, as the prior art cited was irrelevant and the Controller ignored technical data provided.
Abbvie Biotherapeutics Inc & Anr. v.Assistant Controller Of Patents
The appeal challenged the refusal of an Indian patent application for 'ANTI-cMet ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USE'. The appellant sought to amend claims from methods of treatment to product claims. The court upheld the Controller's decision, finding that the original specification focused on method-of-use and the proposed amendments were an impermissible broadening of scope.
Marelli Europe S.P.A. v.The Deputy Controller Of Patents And Designs
Marelli Europe S.P.A. appealed against the Deputy Controller's order refusing grant of a patent application, citing lack of inventive step. The appellant argued that the rejection was mechanical, merely copying prior art extracts without providing reasoned justification for why the invention lacked inventive step. The Court agreed, finding the impugned order lacked proper application of mind.
Fresenius Medical Care Deutschland GmbH v.Controller General Of Patents, Designs And Trademarks and Anr
Fresenius Medical Care Deutschland appealed a decision by the Controller General of Patents refusing to grant its patent application concerning microvesicles derived from adult stem cells for tumor treatment. The core legal dispute centered on whether the appellant could amend the claims at the appellate stage to overcome objections regarding novelty and inventive step. The Delhi High Court ultimately allowed the amendments, finding that they were merely explanatory or disclaimers and did not broaden the scope of the original claims. Consequently, the refusal order was set aside, and the matter was remanded back to the Patent Office for fresh examination.
Cryogas Equipment Private Limited v.Inox India Limited
This Supreme Court judgment addresses a complex dispute concerning alleged copyright infringement related to proprietary engineering drawings used in manufacturing LNG semi-trailers. The core issue was whether these technical drawings fell under the definition of 'design' under the Designs Act, thereby invalidating the claim for copyright protection. The Supreme Court held that determining this mixed question of law and fact could not be done at a preliminary stage (Order VII Rule 11 CPC). Consequently, the appeals were dismissed, and the Commercial Court was directed to conduct a full trial to comprehensively assess all IP claims.
Takeda Pharmaceutical Co Ltd v.Controller Of Patents And Designs And Ors.
Takeda Pharmaceutical appealed a rejection order by the Deputy Controller of Patents & Designs regarding its patent application for Novel Protein Kinase Inhibitors (Brigatinib). The rejection was based on lack of inventive steps and Section 3(d) objections. The High Court allowed the appeal, finding that the respondent failed to consider crucial supplementary data demonstrating Brigatinib's superior selectivity and therapeutic efficacy.
Advanced Electric Machines Group Limited v.The Controller of Patents Designs and Trademark
This appeal challenged the rejection of a patent application concerning an improved electrical sub-assembly for electric/hybrid vehicles, which aimed to enhance Switched Reluctance Machines (SRMs). The petitioner argued that the rejection order lacked reasoning and failed to consider key aspects of the invention. The court found significant procedural flaws in the respondent's decision, including failure to issue a proper Second Examination Report and citing foreign documents without translation. Consequently, the High Court set aside the impugned order and remanded the matter for fresh adjudication.
Syrma Sgs Electronic Pvt Ltd v.The Controller Of Patents & Anr.
The petitioner filed a petition seeking the revocation of Patent No. 483156, which relates to a backpack with an avalanche safety system. The court also addressed several interlocutory applications concerning the submission and exemption of documents. Notice was issued to all respondents for further proceedings.
Fashnear Technologies Private Limited v.John Doe/S And Ors
In a significant interim order, the Delhi High Court granted permanent injunction reliefs sought by Fashnear Technologies Private Limited against John Doe and others. The court issued sweeping directives requiring entities like NPCI, telecom service providers, and Meta Platforms to take immediate action—including blocking UPI IDs, suspending phone numbers, and removing infringing social media content—to protect the plaintiff's trademarks ('MEESHO') and copyrights. This order sets a strong precedent for how IP holders can leverage court intervention against digital infringement across multiple platforms.
UCB Pharma GMBH v.The Controller of Patents and Designs
UCB Pharma appealed an order refusing to proceed with its patent application for a solid dispersion formulation of Rotigotine. The court found that the Controller had caused inordinate delays and violated statutory timelines, compounded by citing new prior art documents at the hearing without proper notification. Consequently, the impugned order was set aside and the matter was remanded for fresh consideration.
Kerry Ingredients India Pvt. Ltd. v.Mr. Navanath Ambre
Kerry Ingredients India Pvt. Ltd. filed appeals challenging the trial court's refusal to grant various ex-parte reliefs, including an interim injunction, appointment of a receiver, and disclosure of sensitive information from former employees (the respondents). The plaintiff alleged that these defendants had divulged confidential company data, client lists, and manufacturing processes after resigning. However, the Gujarat High Court dismissed all appeals, holding that the trial court committed no procedural or jurisdictional error in denying these urgent ex-parte orders.
M/s.STEEL STRIPS WHEELS LIMITED v.WHEELS INDIA LIMITED
The petitioner filed a Transfer Original Petition seeking revocation of Patent No. 269220, granted to Wheels India Limited for 'Vehicle Wheels Having Non-Constant Thickness Rims'. The petitioner raised grounds including lack of novelty and inventive step. The court examined these grounds and partially revoked the patent while maintaining certain claims subject to amendment.
Bts Research International Pty Ltd v.The Controller General of Patents & Designs, Mumbai
The petitioner appealed against the rejection of its patent application, which claimed a method for generating tri-hybrid cells. The Controller rejected the application under Section 3(j) of the Patents Act, arguing that the hybrid cell fell within the definition of naturally occurring organisms or biological processes. The High Court found this conclusion unsubstantiated, noting the artificial and human intervention required to create the synthetic tri-hybrid cells.
M/S. Swagath Urethane Private Limited v.M/S. Tega Industries Limited
This revision petition challenged an order rejecting a petition filed by M/S. Swagath Urethane Private Limited (the defendant in the original suit) under Order 7, Rule 11 CPC. The dispute concerned a patent infringement suit (C.S. No.01 of 2019) where the petitioner argued lack of territorial jurisdiction. The court upheld the original order, finding that the suit was properly filed based on prior judicial directions and the defendant's business location.
Hamdard Laboratories India Medicine Division v.Unani Drugs Manufacturers Association (UDMA)
Hamdard Laboratories India (Medicine Division) appealed against an order dismissing its applications, alleging that UDMA was misleading the public by claiming market dominance and associating Hamdard Food Division products with medicinal claims. The core dispute revolved around the scope of a Family Settlement Deed which divided the HAMDARD Group into Medicine and Food divisions, restricting their respective product lines. The Delhi High Court ultimately dismissed the appeal, noting that the matter fundamentally involved commercial disputes concerning IP rights and required adjudication by a competent Commercial Court.
BIGTEC PRIVATE LIMITED v.The Assistant Controller of Patents and Designs
Bigtec Private Limited appealed the rejection of its Indian Patent Application No.625/CHE/2011 by the Assistant Controller of Patents and Designs. The application related to a method and kit for detecting Hepatitis B Virus (HBV) using specific nucleotide sequences. Bigtec argued that their claimed sequences demonstrated unexpected effects over prior art, countering objections regarding lack of inventive step and patentability under Section 3(c). The Madras High Court set aside the rejection order and remanded the matter for reconsideration by a different officer.
Levi Strauss And Company v.Umesh Chauhan
Levi Strauss And Company filed a suit against Umesh Chauhan and Rajesh Kumar Wadhwa alleging infringement of their registered trademarks, designs, and copyrights related to clothing and jeans. The court found that the plaintiff failed to provide sufficient positive evidence to corroborate the local commissioner's report, leading to the dismissal of the suit.
Vishal Prafulsingh Solanke v.The Controller of Patent and Designs
The Petitioners challenged the Assistant Controller's refusal of their patent application for a 'Thread Type Tamper Evident Security Seal,' which was rejected under Section 25(1)(b) due to lack of novelty/inventive step. The court examined whether the seal provided a technical advancement over cited prior art documents, including US5419599.
Adiuvo Diagnostics Private Limited v.Union of India
Adiuvo Diagnostics Private Limited challenged the granting of Indian Patent No. 439474, which was issued despite a rejected pre-grant opposition filed by the petitioner. The core dispute centered on whether the Controller had adequately reasoned and considered the material evidence presented by both parties regarding novelty and inventive step. Although the court initially questioned the maintainability of the writ petition as an appeal in disguise, it ultimately allowed the petitioner to file a post-grant opposition.
Robert Bosch Limited v.The Deputy Controller of Patents and Designs, Government of India
Robert Bosch Limited appealed the rejection of its patent application (No. 201944047460), which was initially rejected by the Deputy Controller of Patents on grounds including lack of novelty, lack of inventive step, and exclusion under Section 3(m) because it was a method claim. The High Court set aside the rejection based on the finding that the claimed process is an inventive process, not merely a theoretical or mental act, and remanded the matter for re-examination on non-Section 3(m) grounds.
Tekelec, Inc. v.The Controller of Patents
Tekelec appealed an order rejecting its patent application (No. 7133/CHENP/2009) on the grounds that the invention was a non-patentable 'business method' under Section 3(k). The High Court examined the claim and held that since the invention involves using software to improve system functionality for verification, it is not merely a business method. Consequently, the rejection order was set aside and the matter remanded for re-consideration.
F. Hoffmann-La Roche Ag v.Natco Pharma Limited
F. Hoffmann-La Roche filed a suit alleging infringement of its species patent (IN 334397) for the drug Risdiplam, marketed as EVRYSDI®, by Natco Pharma Limited. The plaintiffs sought an interim injunction to restrain the defendant from manufacturing and selling the API. However, the court found that the defendant had raised a credible challenge regarding the validity of the patent. Considering the public interest in affordable medicine for rare diseases like SMA, the court dismissed the application for interim injunction, though it clarified that damages would be payable if the plaintiffs ultimately succeed in the trial.
Neoculi Pty Ltd v.The Controller Of Patents And Designs and Anr.
Neoculi Pty Ltd appealed a rejection order by the Assistant Controller of Patent and Designs, Kolkata, which rejected its application for an antibacterial pharmaceutical composition. The rejection was based on lack of inventive steps, unpatentability under Section 3(e), and insufficient disclosure. The High Court found the impugned order unsustainable due to non-application of mind and remanded the matter.
Caleb Suresh Motupalli v.Controller of Patents
The petitioner filed a Review Application challenging the rejection of his earlier appeal, which had been rejected on both maintainability grounds (Section 117A) and merits. The petitioner argued that patent errors existed in the interpretation of Sections 10(4) and 3(k), specifically concerning technical effect and best mode. The Madras High Court dismissed the review application, finding no error apparent.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.